Relmada Therapeutics (RLMD) EBITDA (2014 - 2021)
Relmada Therapeutics' EBITDA came in at -$34.18 million for Q4 2021, compared with -$20.92 million a year earlier.
Powered by 
Analysis
Relmada Therapeutics (RLMD) EBITDA (2014 - 2021) Analysis & Trends
For FY2021, Relmada Therapeutics' EBITDA was -$125.7 million.
- Going back by year, EBITDA was -$60.83 million in FY2020, -$15.1 million in FY2019, -$6.91 million in FY2018 and -$7.13 million in FY2017.
- The five-year range for quarterly EBITDA is -$43.95 million (Q3 2021) to -$9.97 million (Q1 2020).
- Business Quant data shows RLMD's EBITDA at -$43.95 million (Q3 2021), -$26.46 million (Q2 2021) and -$22.4 million (Q1 2021) in the three quarters before Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Relmada Therapeutics | 361.29 Mn | -197.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -34.18 Mn |
| Sep 30, 2021 | -43.95 Mn |
| Jun 30, 2021 | -26.46 Mn |
| Mar 31, 2021 | -22.40 Mn |
| Dec 31, 2020 | -20.92 Mn |
| Sep 30, 2020 | -19.28 Mn |
| Jun 30, 2020 | -12.76 Mn |
| Mar 31, 2020 | -9.97 Mn |
| Sep 30, 2019 | -3.71 Mn |
| Mar 31, 2019 | -2.70 Mn |
| Dec 31, 2018 | -3.35 Mn |
| Sep 30, 2018 | -1.87 Mn |
| Jun 30, 2018 | -1.40 Mn |
| Mar 31, 2018 | -2.26 Mn |
| Dec 31, 2017 | -1.25 Mn |
| Sep 30, 2017 | -977,489.00 |
| Jun 30, 2017 | -1.76 Mn |
| Mar 31, 2017 | -2.26 Mn |
| Dec 31, 2016 | -1.51 Mn |
| Sep 30, 2016 | -1.60 Mn |
API Access
Relmada Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();